SHAH, N. A.; PAUL, S.; PARVEEN, S.; BHAT, M. H.; ALI, I.; KADLA, S. A. Therapeutic outcome of saroglitazar, a peroxisome proliferator activated receptor α/γ agonist in diabetic and non-diabetic metabolic dysfunction associated steatotic liver disease. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 14, n. 4, p. 519–525, 2025. DOI: 10.18203/2319-2003.ijbcp20251836. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/5904. Acesso em: 23 oct. 2025.